P00523 (SRC_CHICK) Gallus gallus (Chicken)
Proto-oncogene tyrosine-protein kinase Src UniProtKBInterProSTRINGInteractive Modelling
533 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
137 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structural basis for the recognition of c-Src by its inactivator Csk |
Heteromer P41240; | 2×STU; | ||||
| Assess | ||||||
| Structural basis for the recognition of c-Src by its inactivator Csk |
Heteromer P41240; | |||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain in complex with a peptide from the Hepatitis C virus NS5A… |
Heteromer V5RF47; | |||||
| Assess | ||||||
| c-Src Bound to ATP-Competitive Inhibitor I14 | homo-2-mer | 2×I14; | ||||
| Assess | ||||||
| Type II Dasatinib Analog Crystallized with c-Src Kinase | homo-2-mer | 2×4A9; | ||||
| Assess | ||||||
| Crystal structure of the intertwined dimer of the c-Src SH3 domain E93V-S94A-R95S-T96G-N112G-N113Y-… | homo-2-mer | 1×PG4; 1×ACT; | ||||
| Assess | ||||||
| Crystal structure of the intertwined dimer of the c-Src SH3 domain E93V-S94A-R95S-T96G mutant | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of a chimeric c-Src-SH3 domain | homo-2-mer | 2×PGE; | ||||
| Assess | ||||||
| Crystal structure of the v-Src SH3 domain W95R-I96T mutant | homo-2-mer | 4×PEG; 1×PGE; 1×SO4; | ||||
| Assess | ||||||
| Intertwined dimer of the c-Src SH3 domain mutant T126S | homo-2-mer | 4×PEG; 2×PGE; 2×SO4; | ||||
| Assess | ||||||
| Intertwined dimer of the c-Src SH3 domain mutant Q128E | homo-2-mer | 2×PGE; 2×PEG; 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of the intertwined dimer of the c-Src SH3 domain without ATCUN motif | homo-2-mer | 2×PGE; 4×PEG; | ||||
| Assess | ||||||
| Intertwined dimer of the c-Src SH3 domain mutant V111L-N113S-T114S-Q128E at pH 6.0 | homo-2-mer | 2×PGE; 2×PEG; 2×EDO; 4×SO4; | ||||
| Assess | ||||||
| Intertwined dimer of the c-Src SH3 domain mutant E106D | homo-2-mer | 2×PGE; 4×GOL; | ||||
| Assess | ||||||
| Intertwined dimer of the c-Src SH3 domain mutant T125S | homo-2-mer | 2×PEG; 1×SO4; 1×PGE; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of the intertwined dimer of the c-Src tyrosine kinase SH3 domain mutant Q128E | homo-2-mer | 2×PGE; 4×PEG; 2×SO4; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of the intertwined dimer of the c-Src tyrosine kinase SH3 domain mutant Q128R | homo-2-mer | 2×PGE; 6×PEG; | ||||
| Assess | ||||||
| Crystal structure of the c-src-SH3 domain | homo-2-mer | 1×PGE; 1×SO4; 3×ACT; 1×GOL; 2×PG4; | ||||
| Assess | ||||||
| Crystal structure of the c-Src-SH3 domain E97T mutant in complex with the high affinity peptide APP… | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of the intertwined dimer of the c-Src tyrosine kinase SH3 domain mutant N113S | homo-2-mer | 2×PGE; 4×PEG; 2×GOL; 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of the intertwined form of the Src tyrosine kinase SH3 domain T114S-Q128R mutant | homo-2-mer | 2×PGE; 2×SO4; 4×PEG; 2×ACT; | ||||
| Assess | ||||||
| Crystal structure of the intertwined dimer of the c-Src tyrosine kinase SH3 domain mutant S94A | homo-2-mer | 2×PGE; 4×PEG; 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of the intertwined form of the Src tyrosine kinase SH3 domain T96G/Q128R mutant | homo-2-mer | 4×PGE; 4×PEG; 4×SO4; | ||||
| Assess | ||||||
| Intertwined dimer of the c-Src SH3 domain mutant V111L-N113S-T114S | homo-2-mer | 2×PGE; 4×PEG; | ||||
| Assess | ||||||
| Crystal structure of the intertwined dimer of the c-Src tyrosine kinase SH3 domain mutant Q128K | homo-2-mer | 2×PGE; 2×PEG; | ||||
| Assess | ||||||
| CHICKEN SRC TYROSINE KINASE | monomer | |||||
| Assess | ||||||
| Structural basis for the chemical rescue of Src kinase activity | monomer | 1×PP2; | ||||
| Assess | ||||||
| c-Src kinase domain Thr338Ile mutant in complex with ATPgS | monomer | 1×AGS; 1×MG; | ||||
| Assess | ||||||
| c-Src kinase domain in complex with small molecule inhibitor | monomer | 1×IHH; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with a hinge region-binding fragment | monomer | 1×0UL; | ||||
| Assess | ||||||
| Crystal structure of Src kinase domain in complex with covalent inhibitor | monomer | 1×RBS; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with compound 9 | monomer | 1×GUW; | ||||
| Assess | ||||||
| Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib. | monomer | 1×STI; 2×GOL; | ||||
| Assess | ||||||
| Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations | monomer | 1×G6G; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of SRC kinase domain with covalent inhibitor RL3 | monomer | 2×SR2; | ||||
| Assess | ||||||
| Crystal structure of Src kinase domain in complex with covalent inhibitor PD168393 | monomer | 1×DJK; | ||||
| Assess | ||||||
| C-Helix-Out Dasatinib Analog Crystallized with c-Src Kinase | monomer | 1×4B7; | ||||
| Assess | ||||||
| c-SRC kinase domain in complex with RM-1-176 | monomer | 1×I76; | ||||
| Assess | ||||||
| Star 12 bound to analog-sensitive Src kinase | monomer | 1×29K; | ||||
| Assess | ||||||
| Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with S1, a multi… | monomer | 1×ABJ; | ||||
| Assess | ||||||
| c-Src V281C kinase domain in complex with Rao-IV-156 | monomer | 1×S56; | ||||
| Assess | ||||||
| c-Src in complex with ponatinib | monomer | 1×0LI; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with a pyrazolopyrimidine | monomer | 1×RCK; 2×EDO; 1×DMS; | ||||
| Assess | ||||||
| C-Src in complex with ATP-CHCl | monomer | 1×8C6; 1×MG; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with a substituted pyrazolopyrimidine | monomer | 1×11V; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with compound 29B | monomer | 1×GUT; 2×EDO; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with Dasatinib | monomer | 1×1N1; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of T338C c-Src covalently bound to vinylsulfonamide-pyrazolopyrimidine 9 | monomer | 1×VSP; | ||||
| Assess | ||||||
| Crystal structure of drug resistant SRC kinase domain | monomer | 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of drug resistant SRC kinase domain with irreversible inhibitor | monomer | 1×SR2; | ||||
| Assess | ||||||
| crystal structure of the L317I mutant of the chicken c-Src tyrosine kinase domain complexed with im… | monomer | 1×STI; 1×ACT; 1×GOL; | ||||
| Assess | ||||||
| Drug resistant cSrc kinase domain in complex with covalent inhibitor PD168393 | monomer | 1×DJK; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with inhibitor RL37 (Type III) | monomer | 2×1AW; | ||||
| Assess | ||||||
| c-Src kinase domain in complex with Rao-IV-151 | monomer | 1×73A; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with inhibitor RL38 (Type III) | monomer | 2×1AU; | ||||
| Assess | ||||||
| Drug resistant cSrc kinase domain in complex with inhibitor RL45 (Type II) | monomer | 1×1BU; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with inhibitor RL45 (Type II) | monomer | 1×1BU; | ||||
| Assess | ||||||
| Discovery of a small molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDG… | monomer | 1×NG7; 1×MES; 1×GOL; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with RL104 | monomer | 1×AQM; | ||||
| Assess | ||||||
| crystal structure of the L317I mutant of the chicken c-Src tyrosine kinase domain | monomer | |||||
| Assess | ||||||
| Crystal structure of c-Src in complex with pyrazolopyrimidine 3 | monomer | 1×PD3; | ||||
| Assess | ||||||
| Crystal structure of 1NM-PP1 bound to analog-sensitive Src kinase | monomer | 1×0JN; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with RL40 | monomer | 1×G97; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with RL130 | monomer | 1×AQU; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with RL103 | monomer | 1×AQB; | ||||
| Assess | ||||||
| C-Src in complex with FIIN-2 | monomer | 1×37O; 2×SO4; | ||||
| Assess | ||||||
| Src kinase in complex with a sulfonamide inhibitor | monomer | 1×6G3; | ||||
| Assess | ||||||
| c-SRC kinase domain in complex with bumpless BKI analog UW1243 | monomer | 1×B5A; | ||||
| Assess | ||||||
| c-SRC kinase domain in complex with BKI RM-1-89 | monomer | 1×BK5; | ||||
| Assess | ||||||
| Crystal structure of c-Src in complex with pyrazolopyrimidine 5 | monomer | 1×PD5; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with RL235 | monomer | 1×GOL; 1×56G; | ||||
| Assess | ||||||
| Src Thr338Ile inhibited in the DFG-Asp-Out conformation | monomer | |||||
| Assess | ||||||
| c-Src V281C kinase domain in complex with Rao-IV-151 | monomer | 1×71D; | ||||
| Assess | ||||||
| Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP121, a mu… | monomer | 1×KS1; | ||||
| Assess | ||||||
| C-Src in complex with TAS-120 | monomer | 1×TZ0; | ||||
| Assess | ||||||
| Kinase domain of cSrc in complex with RL236 | monomer | 1×563; | ||||
| Assess | ||||||
| Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with pyrazolopy… | monomer | 1×PD5; | ||||
| Assess | ||||||
| Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with dasatinib | monomer | 1×1N1; | ||||
| Assess | ||||||
| c-Src V281C bound to N-[3-({6-[(1E)-2-cyano-3-(methylamino)-3-oxoprop-1-en-1-yl]-7-(2-methoxyethyl)… | monomer | 1×72F; | ||||
| Assess | ||||||
| Src in complex with DNA-templated macrocyclic inhibitor MC4b | monomer | 3×GOL; 5×SO4; | ||||
| Assess | ||||||
| C-Src in complex with ATP-Chf | monomer | 1×8BU; 1×MG; | ||||
| Assess | ||||||
| C-Src in complex with Ruxolitinib | monomer | 1×RXT; | ||||
| Assess | ||||||
| chicken c-Src kinase domain in complex with ATPgS | monomer | 1×AMP; | ||||
| Assess | ||||||
| Crystal structure of c-SRC in complex with a covalent lysine probe | monomer | 1×O44; | ||||
| Assess | ||||||
| Src in complex with DNA-templated macrocyclic inhibitor MC25b | monomer | |||||
| Assess | ||||||
| Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP102, a mu… | monomer | |||||
| Assess | ||||||
| Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP494, a mu… | monomer | 1×KS4; | ||||
| Assess | ||||||
| Src in complex with DNA-templated macrocyclic inhibitor MC1 | monomer | |||||
| Assess | ||||||
| C-Src in complex with ibrutinib | monomer | 1×1E8; | ||||
| Assess | ||||||
| Structure of 3MB-PP1 bound to analog-sensitive Src kinase | monomer | 1×VGG; | ||||
| Assess | ||||||
| SRC SH2 THREF1TRP MUTANT | monomer | 1×PO4; | ||||
| Assess | ||||||
| SRC SH2 THREF1TRP MUTANT COMPLEXED WITH THE PHOSPHOPEPTIDE S(PTR)VNVQN | monomer | |||||
| Assess | ||||||
| Crystal Structure of the Src SH2 Domain Complexed with Peptide (SDpYANFK) | monomer | 2×CAC; | ||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain mutant L100I at pH 3.0 | monomer | 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of c-Src SH3 domain without ATCUN motif: monomer 2 | monomer | 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain mutant V111L-N113S-T114S at pH 7.0 | monomer | |||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain mutant E93V-S94A-R95S-T96G-N112G-N113Y-T114N-E115H in com… | monomer | |||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain mutant V111L-N113S-T114S in 7 M urea | monomer | 8×URE; | ||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain mutant V111L-N113S-T114S in 3 M urea | monomer | 6×URE; | ||||
| Assess | ||||||
| Crystal structure of the v-Src SH3 domain Q128R mutant | monomer | 1×PG4; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of c-Src SH3 domain without ATCUN motif: monomer 1 | monomer | |||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain mutant S94A-T98D-V111L-N113S-T114S at pH 4.5 | monomer | |||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain mutant S94A-T98D-V111L-N113S-T114S at pH 3.0 | monomer | 2×FMT; | ||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain mutant V111L-N113S-T114S-Q128E at pH 6.0 | monomer | 1×MES; | ||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain mutant S94A-T98D-V111L-N113S-T114S at pH 7.0 | monomer | |||||
| Assess | ||||||
| Crystal structure of the v-Src SH3 domain N117D-V124L mutant | monomer | 1×GLY; | ||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain mutant V111L-N113S-T114S-Q128E at pH 7.0 | monomer | |||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain N112G-N113Y-T114N-E115H mutant | monomer | |||||
| Assess | ||||||
| High resolution crystal structure of the c-Src-SH3 domain mutant E93V in complex with the high affi… | monomer | |||||
| Assess | ||||||
| Crystal structure of the c-Src-SH3 domain in complex with the high affinity peptide VSL12 | monomer | 1×NI; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of the T98E c-Src-SH3 domain mutant in complex with the high affinity peptide VSL… | monomer | 1×ACE; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of the T98D c-Src-SH3 domain mutant in complex with the high affinity peptide APP… | monomer | 1×SO4; 2×ACE; | ||||
| Assess | ||||||
| Crystal structure of the c-Src tyrosine kinase SH3 domain mutant Q128E | monomer | 1×NI; 1×EPE; | ||||
| Assess | ||||||
| Crystal structure of a chimeric c-Src-SH3 domain with the sequence of the RT-loop from the Abl-SH3 … | monomer | |||||
| Assess | ||||||
| Crystal structure of the c-Src-SH3 domain Q128R mutant in complex with the high affinity peptide AP… | monomer | |||||
| Assess | ||||||
| Crystal structure of the c-Src-SH3 domain Q128E mutant in complex with the high affinity peptide AP… | monomer | 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of the c-Src-SH3 domain E93V/Q128R mutant in complex with the high affinity pepti… | monomer | 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain H122R-Q128K mutant in complex with Cu(II) at pH 7.5 co-cr… | monomer | 1×ZB1; 1×CU; | ||||
| Assess | ||||||
| Crystal structure of the c-Src-SH3 domain in complex with the high affinity peptide APP12 | monomer | 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain H122R-Q128K mutant in complex with Ni(II) at pH 7.5 co-cr… | monomer | 1×ZB1; 1×NI; | ||||
| Assess | ||||||
| Crystal structure of the Src tyrosine kinase SH3 domain T96G/Q128R mutant | monomer | 1×NI; 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain H122R-Q128E mutant in complex with Ni(II) at pH 7.5 co-cr… | monomer | 1×ZB1; 1×NI; | ||||
| Assess | ||||||
| Crystal structure of the T98E c-Src-SH3 domain mutant in complex with the high affinity peptide APP… | monomer | 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain H122R-Q128E mutant in complex with Cu(II) at pH 6.5 co-cr… | monomer | 1×ZB1; 1×CU; | ||||
| Assess | ||||||
| Crystal structure of the Src tyrosine kinase SH3 domain S94A/Q128R mutant in complex with the high … | monomer | |||||
| Assess | ||||||
| Crystal structure of the c-Src SH3 domain E93V-S94A-R95S-T96G mutant | monomer | |||||
| Assess | ||||||
| Crystal structure of chicken c-Src-SH3 domain: monomeric form | monomer | 1×NI; 1×EPE; | ||||
| Assess | ||||||
| Crystal structure of a chimeric c-Src-SH3 domain with the sequence of the RT-loop from the Abl-SH3 … | monomer | 2×PEG; | ||||
| Assess | ||||||
| Crystal structure of the chicken c-Src-SH3 domain intertwined dimer | monomer | 1×PGE; 2×PEG; | ||||
| Assess | ||||||
| TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIG… | monomer | |||||
| Assess | ||||||
| STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE | monomer | |||||
| Assess | ||||||
| TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIG… | monomer | |||||
| Assess | ||||||
| STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE | monomer | |||||
| Assess | ||||||
| TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIG… | monomer | |||||
| Assess | ||||||
| 1H AND 15N ASSIGNMENTS AND SECONDARY STRUCTURE OF THE SRC SH3 DOMAIN | monomer | |||||
| Assess | ||||||
| TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIG… | monomer | |||||
| Assess | ||||||
| 1H AND 15N ASSIGNMENTS AND SECONDARY STRUCTURE OF THE SRC SH3 DOMAIN | monomer | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2h8h.1.A | monomer | 0.83 | 1×H8H; | 94.55 | ||
| Assess | ||||||
| 1y57.1.A | monomer | 0.82 | 1×MPZ; | 98.67 | ||
| Assess | ||||||